New York Life Investment Management LLC Buys 9,463,171 Shares of NYLIM U.S. Large Cap R&D Leaders ETF $LRND

New York Life Investment Management LLC purchased a new position in shares of NYLIM U.S. Large Cap R&D Leaders ETF (NASDAQ:LRND) during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 9,463,171 shares of the company’s stock, valued at approximately $452,368,000. NYLIM U.S. Large Cap R&D Leaders ETF comprises 3.1% of New York Life Investment Management LLC’s portfolio, making the stock its 4th biggest position. New York Life Investment Management LLC owned about 1.00% of NYLIM U.S. Large Cap R&D Leaders ETF at the end of the most recent reporting period.

NYLIM U.S. Large Cap R&D Leaders ETF Stock Down 0.9%

Shares of NASDAQ:LRND opened at $43.81 on Wednesday. The business has a fifty day moving average of $46.72 and a two-hundred day moving average of $43.55. The stock has a market cap of $411.81 million, a P/E ratio of 27.08 and a beta of 1.11. NYLIM U.S. Large Cap R&D Leaders ETF has a 52-week low of $35.87 and a 52-week high of $49.31.

NYLIM U.S. Large Cap R&D Leaders ETF Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 2nd. Investors of record on Wednesday, September 30th were issued a $0.0439 dividend. This is a decrease from NYLIM U.S. Large Cap R&D Leaders ETF’s previous quarterly dividend of $0.0456. The ex-dividend date was Wednesday, September 30th. This represents a $0.18 annualized dividend and a yield of 0.4%.

About NYLIM U.S. Large Cap R&D Leaders ETF

The IQ U.S. Large Cap R&D Leaders ETF (LRND) is an exchange-traded fund that is based on the IQ U.S. Large Cap R&D Leaders index. The fund tracks an index of 100 large-cap US companies selected and weighted based on the most recently reported one year research and development (R&D) spending. LRND was launched on Feb 8, 2022 and is managed by IndexIQ.